José Barrueco

Boehringer Ingelheim (United States)

1

h-index

1

Publications

923

Citations

Publications

1 shown

Docetaxel plus nintedanib versus docetaxel plus placebo in patients with previously treated non-small-cell lung cancer (LUME-Lung 1): a phase 3, double-blind, randomised controlled trial

Martin Reck , R. Kaiser , Anders Mellemgaard +11 more

2014 The Lancet Oncology 923 citations

Frequent Co-Authors

Martin Reck

German Center for Lung Research

R. Kaiser

Boehringer Ingelheim (Germany)

Anders Mellemgaard

Herlev Hospital

Jean‐Yves Douillard

Universitair Ziekenhuis Leuven

С. В. Орлов

First Pavlov State Medical University of St. Petersburg

Maciej Krzakowski

The Maria Sklodowska-Curie National Research Institute of Oncology

Researcher Info

h-index: 1
Publications: 1
Citations: 923
Institution: Boehringer Ingelheim (United States)

External Links

Google Scholar

Impact Metrics

h-index 1

h-index: Number of publications with at least h citations each.